339 related articles for article (PubMed ID: 27247947)
21. FGF21 attenuates pathological myocardial remodeling following myocardial infarction through the adiponectin-dependent mechanism.
Joki Y; Ohashi K; Yuasa D; Shibata R; Ito M; Matsuo K; Kambara T; Uemura Y; Hayakawa S; Hiramatsu-Ito M; Kanemura N; Ogawa H; Daida H; Murohara T; Ouchi N
Biochem Biophys Res Commun; 2015 Mar; 459(1):124-30. PubMed ID: 25712519
[TBL] [Abstract][Full Text] [Related]
22. The Role of Fibroblast Growth Factor 21 in Diabetic Cardiovascular Complications and Related Epigenetic Mechanisms.
Xiao M; Tang Y; Wang S; Wang J; Wang J; Guo Y; Zhang J; Gu J
Front Endocrinol (Lausanne); 2021; 12():598008. PubMed ID: 34349728
[TBL] [Abstract][Full Text] [Related]
23. Rush to the fire: FGF21 extinguishes metabolic stress, metaflammation and tissue damage.
Luo Y; Ye S; Chen X; Gong F; Lu W; Li X
Cytokine Growth Factor Rev; 2017 Dec; 38():59-65. PubMed ID: 28887067
[TBL] [Abstract][Full Text] [Related]
24. Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes.
Xiao Y; Liu L; Xu A; Zhou P; Long Z; Tu Y; Chen X; Tang W; Huang G; Zhou Z
Cardiovasc Diabetol; 2015 Jun; 14():72. PubMed ID: 26047614
[TBL] [Abstract][Full Text] [Related]
25. Autophagic control of cardiac steatosis through FGF21 in obesity-associated cardiomyopathy.
Rupérez C; Lerin C; Ferrer-Curriu G; Cairo M; Mas-Stachurska A; Sitges M; Villarroya J; Giralt M; Villarroya F; Planavila A
Int J Cardiol; 2018 Jun; 260():163-170. PubMed ID: 29519677
[TBL] [Abstract][Full Text] [Related]
26. N-3 polyunsaturated fatty acids increase hepatic fibroblast growth factor 21 sensitivity via a PPAR-γ-β-klotho pathway.
Yang W; Chen X; Liu Y; Chen M; Jiang X; Shen T; Li Q; Yang Y; Ling W
Mol Nutr Food Res; 2017 Sep; 61(9):. PubMed ID: 28371258
[TBL] [Abstract][Full Text] [Related]
27. Ultrasound-assisted C
Gao J; Liu J; Meng Z; Li Y; Hong Y; Wang L; He L; Hu B; Zheng Y; Li T; Cui D; Shen E
Acta Biomater; 2021 Aug; 130():395-408. PubMed ID: 34129954
[TBL] [Abstract][Full Text] [Related]
28. Fibroblast growth factor 21 inhibits atherosclerosis in apoE-/- mice by ameliorating Fas-mediated apoptosis.
Yan X; Gou Z; Li Y; Wang Y; Zhu J; Xu G; Zhang Q
Lipids Health Dis; 2018 Aug; 17(1):203. PubMed ID: 30157856
[TBL] [Abstract][Full Text] [Related]
29. Fibroblast growth factor 21 protects mouse brain against D-galactose induced aging via suppression of oxidative stress response and advanced glycation end products formation.
Yu Y; Bai F; Wang W; Liu Y; Yuan Q; Qu S; Zhang T; Tian G; Li S; Li D; Ren G
Pharmacol Biochem Behav; 2015 Jun; 133():122-31. PubMed ID: 25871519
[TBL] [Abstract][Full Text] [Related]
30. Fibroblast growth factor 21 (FGF21) therapy attenuates left ventricular dysfunction and metabolic disturbance by improving FGF21 sensitivity, cardiac mitochondrial redox homoeostasis and structural changes in pre-diabetic rats.
Tanajak P; Sa-Nguanmoo P; Wang X; Liang G; Li X; Jiang C; Chattipakorn SC; Chattipakorn N
Acta Physiol (Oxf); 2016 Aug; 217(4):287-99. PubMed ID: 27119620
[TBL] [Abstract][Full Text] [Related]
31. Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice.
Lin Z; Pan X; Wu F; Ye D; Zhang Y; Wang Y; Jin L; Lian Q; Huang Y; Ding H; Triggle C; Wang K; Li X; Xu A
Circulation; 2015 May; 131(21):1861-71. PubMed ID: 25794851
[TBL] [Abstract][Full Text] [Related]
32. Fibroblast growth factor 21 deletion aggravates diabetes-induced pathogenic changes in the aorta in type 1 diabetic mice.
Yan X; Chen J; Zhang C; Zeng J; Zhou S; Zhang Z; Lu X; Chen J; Feng W; Li X; Tan Y
Cardiovasc Diabetol; 2015 Jun; 14(1):77. PubMed ID: 27391008
[TBL] [Abstract][Full Text] [Related]
33. Cardioprotective effects of fibroblast growth factor 21 against doxorubicin-induced toxicity via the SIRT1/LKB1/AMPK pathway.
Wang S; Wang Y; Zhang Z; Liu Q; Gu J
Cell Death Dis; 2017 Aug; 8(8):e3018. PubMed ID: 28837153
[TBL] [Abstract][Full Text] [Related]
34. Comparisons of cardioprotective efficacy between fibroblast growth factor 21 and dipeptidyl peptidase-4 inhibitor in prediabetic rats.
Tanajak P; Sa-Nguanmoo P; Apaijai N; Wang X; Liang G; Li X; Jiang C; Chattipakorn SC; Chattipakorn N
Cardiovasc Ther; 2017 Aug; 35(4):. PubMed ID: 28391633
[TBL] [Abstract][Full Text] [Related]
35. The roles of FGF21 in atherosclerosis pathogenesis.
Tabari FS; Karimian A; Parsian H; Rameshknia V; Mahmoodpour A; Majidinia M; Maniati M; Yousefi B
Rev Endocr Metab Disord; 2019 Mar; 20(1):103-114. PubMed ID: 30879171
[TBL] [Abstract][Full Text] [Related]
36. Fibroblast Growth Factor 21 As an Emerging Therapeutic Target for Type 2 Diabetes Mellitus.
So WY; Leung PS
Med Res Rev; 2016 Jul; 36(4):672-704. PubMed ID: 27031294
[TBL] [Abstract][Full Text] [Related]
37. Impact of Diabetes on Cardiac and Vascular Disease: Role of Calcium Signaling.
Smani T; Gallardo-Castillo I; Ávila-Médina J; Jimenez-Navarro MF; Ordoñez A; Hmadcha A
Curr Med Chem; 2019; 26(22):4166-4177. PubMed ID: 28545369
[TBL] [Abstract][Full Text] [Related]
38. FGF21 represses cerebrovascular aging via improving mitochondrial biogenesis and inhibiting p53 signaling pathway in an AMPK-dependent manner.
Wang XM; Xiao H; Liu LL; Cheng D; Li XJ; Si LY
Exp Cell Res; 2016 Aug; 346(2):147-56. PubMed ID: 27364911
[TBL] [Abstract][Full Text] [Related]
39. Fibroblast growth factor 21 protects rat cardiomyocytes from endoplasmic reticulum stress by promoting the fibroblast growth factor receptor 1-extracellular signal‑regulated kinase 1/2 signaling pathway.
Liang P; Zhong L; Gong L; Wang J; Zhu Y; Liu W; Yang J
Int J Mol Med; 2017 Nov; 40(5):1477-1485. PubMed ID: 28949374
[TBL] [Abstract][Full Text] [Related]
40. Modulation of energy balance by fibroblast growth factor 21.
Cuevas-Ramos D; Aguilar-Salinas CA
Horm Mol Biol Clin Investig; 2016 Jun; 30(1):. PubMed ID: 27318658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
